ASSESSMENT OF EFFECTIVE USE OF ANTI-EPILEPTIC DRUG THERAPY AMONG PATIENTS AT KAGANDO HOSPITAL

  • Type: Project
  • Department: Pharmaceutical Science
  • Project ID: PHS0069
  • Access Fee: ₦5,000 ($14)
  • Pages: 37 Pages
  • Format: Microsoft Word
  • Views: 343
  • Report This work

For more Info, call us on
+234 8130 686 500
or
+234 8093 423 853

TABLE OF CONTENTS

DECLARATION ............................................................................................................................... i

ACKNOWLEDGEMENT ................................................................................................................ ii

DEDICATION ................................................................................................................................. iii

TABLE OF CONTENTS ................................................................................................................ iv

ABBREVIATIONS ........................................................................................................................ vii

CHAPTER ONE .............................................................................................................................. 1

1.0 INTRODUCTION ............................................................................................................... 1

1.1.0 Background ............................................................................................................................. 1

1.2.0Problem statement. .................................................................................................................. 2

1.3.0Research questions ................................................................................................................... 3

1.4.00bjectives ................................................................................................................................ 3

1.4.1 General objectives ................................................................................................................... 3

1.4.2 Specific objectives. ................................................................................................................. 4

1.5.0Justification of the study .......................................................................................................... 4

1.6.0Significance of the study ......................................................................................................... 5

CHAPTER TWO ......................................................................................................................... 6

2.0 LITERATURE REVIEW ...................................................................................................... 6

2.1.0 Causes and symptoms of seizures ....................................................................................... 6

2.2.0 Epilepsy and genes ............................................................................................................. 7

2.3.0 Epilepsy and anti-epileptic drugs ........................................................................................ 7

2.4.0Epilepsy in Africa ................................................................................................................ 9

2.5.0 Adherence to epileptic therapy ........................................................................................... 9

CHAPTER THREE ............................................................................................................... 11

3.0 METHODOLOGY AND MATERIALS ......................................................................... ll

3.1.0 Study design .................................................................................................................. 11

3.2.0 Study area ..................................................................................................................... 11

3.3.0 Study population ........................................................................................................... 11

3.4.0 Selection criteria ........................................................................................................... 11

3.~.0 Population and sampling ............................................................................................... 12

3.6.0 Sampling procedure ...................................................................................................... 12

3.7.0 Tools and data collection methods ................................................................................ 12

3.8.0 Data collection .............................................................................................................. 12

3.9.0 Data analysis ................................................................................................................. 12

3.10.0 Ethical considerations ................................................................................................. 13

iv

3.10.1 Limitation of the study ................................................................................................ 13

CHAPTER FOUR ................................................................................................................. 14

4.0 RESULTS ........................................................................................................................ 14

4.1.0 DEMORGRAPHIC DATA .......................................................................................... 14

TABLE !.Showing the demographic distribution and social economic filctors of the

participants ............................................................................................................................. 15

4.2.0 ASSESSMENT OF THE PATIENT/PHYSICIAN RELATIONSHIP AND

PATJENT/DISPENSER OR PHARMACIST RELATIONSHIP ......................................... 16

TABLE 2. Showing patient/physician relationship and patient/dispenser questions and advice

offered to patients .................................................................................................................. 16

4.3.0 THE PERCENTAGE PROPORTION OF ADHERENT PATIENTS TO

THEIR ANTI-EPILEPTIC MEDICATION .......................................................................... 16

TABLE 3, showing the percentage proportion of adherent patients ...................................... 17

4.4.0 THE DETAILED ACCOUNT OF THE NON-ADHERENT PATIENTS (TIME

FACTOR AND THE REASONS FOR NON-ADHERENCE) ............................................. 17

TABLE 4; showing the detailed account of non-adherent patients ....................................... 17

GRAPH 1 ............................................................................................................................... 18

4.6.0 FACTORS AFFECTING ADHERENCE (N=38) ....................................................... 19

4.7.0 PATIENT'S ATTITUDE TOWARDS HIS/HER ABILITY TO COMPLY AND

WHETHER HE/SHE BELIEVES THERAPY IS BENEFICIAL. ........................................ 19

TABLES, showing the demographic and social economic factors among the non-adherent

patients ................................................................................................................................... 20

Table 6, showing physician factors and dispenser questions and advise to patients who did not

adhere ..................................................................................................................................... 21

CHAPTER FIVE ................................................................................................................... 22

5.1.0 DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS................................. 22

5.1.1 DISCUSSION ............................................................................................................. 22

5.1.2CONCLUSION .............................................................................................................. 23

5.1.3 RECOMMENDATIONS .............................................................................................. 23

REFERENCES . ..................................................................................................................... 24

Appendix 1: ............................................................................................................................ 25

QUESTIONNAIRE ............................................................................................................... 25

Appe~dix l 1 ............................................................................................................................ 28

RESEARCH BUDGET ......................................................................................................... 28

Appendix II! ......................................................................................................................... 28

TIME FRAME ....................................................................................................................... 28

Appendix IV .......................................................................................................................... 29

CHAPTER ONE 1.0 INTRODUCTION. Epilepsy is a chronic condition characterized by recurrent unprovoked seizures caused by abnormal discharges in the brain. (UCG, 20 16). It is one of the most common neurologic disorders affecting over 50million people worldwide with no boundary to age, race, social class and geographical locality. Among patients who have epilepsy, 85% of them found in developing countries (an estimate of 40million) do not receive appropriate treatment. (WHO, 2014) Globally epilepsy is the third most common neurologic disorder after cerebral vascular and Alzheimer's disease. Epilepsy is an assortment of different seizure types originating from several mechanisms that have a sudden discharge of cerebral neurons. The abnormal electrical activity may result in loss of consciousness, abnormal movements, atypical or odd behavior and distorted perceptions of limited duration but recur if untreated. In most cases, epilepsy has no identifiable cause however focal areas that are functionally abnormal may be triggered by alteration in blood gases, PH, electrolytes, blood glucose levels and changes in environmental factors such as sleep deprivation, alcohol intake and stress. Therefore in most cases epilepsy is referred to as idiopathic since the cause is not always known.

ASSESSMENT OF EFFECTIVE USE OF ANTI-EPILEPTIC DRUG THERAPY AMONG PATIENTS AT KAGANDO HOSPITAL
For more Info, call us on
+234 8130 686 500
or
+234 8093 423 853

Share This
  • Type: Project
  • Department: Pharmaceutical Science
  • Project ID: PHS0069
  • Access Fee: ₦5,000 ($14)
  • Pages: 37 Pages
  • Format: Microsoft Word
  • Views: 343
Payment Instruction
Bank payment for Nigerians, Make a payment of ₦ 5,000 to

Bank GTBANK
gtbank
Account Name Obiaks Business Venture
Account Number 0211074565

Bitcoin: Make a payment of 0.0005 to

Bitcoin(Btc)

btc wallet
Copy to clipboard Copy text

500
Leave a comment...

    Details

    Type Project
    Department Pharmaceutical Science
    Project ID PHS0069
    Fee ₦5,000 ($14)
    No of Pages 37 Pages
    Format Microsoft Word

    Related Works

    TABLE OF CONTENTS DECLARATION ............................................................................................................................... i ACKNOWLEDGEMENT ................................................................................................................ ii DEDICATION... Continue Reading
    ABSTRACT This study was carried out to evaluate the levels of serum lipids in tuberculosis (TB) subjects on anti-tuberculosis therapy. A total of 60 subjects were recruited for this study. 20 subjects were cases tuberculosis patients not on therapy, 20 were tuberculosis subjects on anti-TB therapy for at least three months, and another 20 were... Continue Reading
    ABSTRACT HIV/ AIDS is an epidemic that is most prevalent in Uganda affecting people of different age groups, occupations and gender. It has a severe impact on the health status of the affected individuals. With the increase in the transmission of HIV, there is also an increase in the existence of TB as a co-infection. In this context, the aim of... Continue Reading
    ABSTRACT Since the identification of the first human immunodeficiency virus (HIV) case, developments have been underway to find treatment for the virus. Antiretroviral agents, especially when used in highly active antiretroviral therapy (HAART) regimens, have produced dramatic decreases in morbidity and mortality of HIV infected people and has... Continue Reading
    Table of Contents ABSTRACT........................................................................................................................ i DEDICATION.................................................................................................................. iv ACKNOWLEDGMENT... Continue Reading
    ABSTRACT Background: There are over 36.9 million people globally living with HIV/AIDS, 35.4 million people have died from AIDS-related illnesses since the start of the epidemic and Sub-Saharan Africa carries 70% of the global burden of infection. While there has been a gradual increase in the number of HIV/AIDS patients accessing treatment, 33% of... Continue Reading
    This study was set to examine factors affecting adherence to ARVs among HIV/AIDS patients attending Kawolo Hospital HIV Clinic Buikwe District. Adherence is an indication of the degree to which patients follow advice regarding the long term treatment (Hsu, 2005).Adherence involves a mutual decision making process between the patient and the health... Continue Reading
    ABSTRACT INTRODUCTION This study assessed the factors influencing drug regimen compliance among diabetes patient  Asubiaro State hospital Osogbo in Osun State. The objective of the study was to assess the  factors influencing drug regimen compliance among diabetes patient. METHODOLOGY A descriptive design was employed for the study. Convenient... Continue Reading
    ABSTRACT INTRODUCTION This study assessed the factors influencing drug regimen compliance among diabetes patient Asubiaro State hospital Osogbo in Osun State. The objective of the study was to assess the factors influencing drug regimen compliance among diabetes patient. METHODOLOGY A descriptive design was employed for the study. Convenient... Continue Reading
    TABLE OF CONTENTS DEDICATION...............................................................................................................................iii DECLARATION ........................................................................................................................... iv... Continue Reading
    Call Us
    whatsappWhatsApp Us